EGFR and neoplasm: In particular, some of the most significant genes according to our approach, like FUBP1, NOTCH1, PTEN, EGFR, and NF1, were mutated in less than 10% of the patients within that tumor type (Fig. 1c), indicating that mutations in these genes are strongly associated with global changes in expression.